« Previous
Next »
Heart Rhythm
Volume 9, Issue 5
, Pages 760-769
, May 2012
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents
To access this article, please choose from the options below
Dr Antzelevitch was supported by a grant from the National, Heart, Lung, and Blood Institute (grant number HL47678), grants from NYSTEM, and the Masons of New York State and Florida. Dr Ackerman was supported by the Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program and the National Institutes of Health (grant number HD42569). Dr Casis was supported by a grant from MICINN (grant number SAF2010-16120/).
The first four authors contributed equally.
Dr Ackerman is a consultant for Transgenomic and its FAMILION genetic test for cardiac ion channel abnormalities. In addition, “cardiac channel gene screen” and “know-how relating to long QT genetic testing” license agreements, resulting in consideration and royalty payments, were established between Genaissance Pharmaceuticals (then PGxHealth and now Transgenomic, Omaha, Neb) and Mayo Medical Ventures (now Mayo Clinic Health Solutions, Rochester, Minn) in 2004. However, Transgenomic did not provide financial support for this study. The other authors have no financial or other considerations to disclose.
PII: S1547-5271(11)01461-5
doi: 10.1016/j.hrthm.2011.12.006
© 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Heart Rhythm
Volume 9, Issue 5
, Pages 760-769
, May 2012
